Cargando…

Trimodality PET/CT/MRI and Radiotherapy: A Mini-Review

Computed tomography (CT) has revolutionized external radiotherapy by making it possible to visualize and segment the tumors and the organs at risk in a three-dimensional way. However, if CT is a now a standard, it presents some limitations, notably concerning tumor characterization and delineation....

Descripción completa

Detalles Bibliográficos
Autores principales:	Decazes, Pierre, Hinault, Pauline, Veresezan, Ovidiu, Thureau, Sébastien, Gouel, Pierrick, Vera, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890017/ https://www.ncbi.nlm.nih.gov/pubmed/33614497 http://dx.doi.org/10.3389/fonc.2020.614008

Ejemplares similares

Characterization of positioning uncertainties in PET‐CT‐MR trimodality solutions for radiotherapy
por: Hinault, Pauline, et al.
Publicado: (2022)

Synthetic MRI for Radiotherapy Planning for Brain and Prostate Cancers: Phantom Validation and Patient Evaluation
por: Gouel, Pierrick, et al.
Publicado: (2022)

Advances in PET and MRI imaging of tumor hypoxia
por: Gouel, Pierrick, et al.
Publicado: (2023)

Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx Cancers
por: Gouel, Pierrick, et al.
Publicado: (2023)

Impact of the Bayesian penalized likelihood algorithm (Q.Clear®) in comparison with the OSEM reconstruction on low contrast PET hypoxic images
por: Texte, Edgar, et al.
Publicado: (2020)

Prognostic value of post-induction chemotherapy (18)F-FDG PET-CT in stage II/III non-small cell lung cancer before (chemo-) radiation
por: Ganem, Julien, et al.
Publicado: (2019)

FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer
por: Thureau, Sébastien, et al.
Publicado: (2018)

Angiogenesis imaging study using interim [(18)F] RGD-K5 PET/CT in patients with lymphoma undergoing chemotherapy: preliminary evidence
por: Tonnelet, David, et al.
Publicado: (2021)

A new methodology to derive 3D kinetic parametric FDG PET images based on a mathematical approach integrating an error model of measurement
por: Colard, Elyse, et al.
Publicado: (2018)

First experiences with PET-MRI/CT in radiotherapy planning for cervical cancer
por: Scharl, Sophia, et al.
Publicado: (2022)

First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer
por: Thureau, Sébastien, et al.
Publicado: (2021)

The role of PET/CT in radiotherapy for nasopharyngeal carcinoma
por: Li, Hongjia, et al.
Publicado: (2022)

Using 18F-FDG-PET/CT Metrics to Predict Survival in Ra-Dio-Iodine Refractory Thyroid Cancers
por: Roy, Malanie, et al.
Publicado: (2022)

PET/CT in Radiotherapy Planning for Head and Neck Cancer
por: Newbold, Katie, et al.
Publicado: (2012)

The use of PET/CT in radiotherapy planning: contribution of deformable registration
por: Delikgoz Soykut, Ela, et al.
Publicado: (2013)

Intraindividual Comparison Between [(18)F] PSMA-1007 PET/CT and Multiparametric MRI for Radiotherapy Planning in Primary Prostate Cancer Patients
por: Marinescu, Ioana M., et al.
Publicado: (2022)

Progress and Future Trends in PET/CT and PET/MRI Molecular Imaging Approaches for Breast Cancer
por: Ming, Yue, et al.
Publicado: (2020)

Trimodality Therapy for Bladder Preservation in the Elderly Population with Invasive Bladder Cancer
por: Turgeon, Guy-Anne, et al.
Publicado: (2014)

Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier
por: Desbordes, Paul, et al.
Publicado: (2017)

Can PSMA PET/CT help in dose-tailoring in post-prostatectomy radiotherapy?
por: Champion, Ambroise, et al.
Publicado: (2023)

Synthetic CT generation for MRI-guided adaptive radiotherapy in prostate cancer
por: Hsu, Shu-Hui, et al.
Publicado: (2022)

Risk stratification of postoperative cardiopulmonary toxicity after trimodality therapy for esophageal cancer
por: Kowalchuk, Roman O., et al.
Publicado: (2023)

Value of (18)F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With (18)F-FDG PET/CT, MRI, and Contrast-Enhanced CT
por: Wang, Fei, et al.
Publicado: (2022)

Prospective Evaluation of Sarcopenia in Head and Neck Cancer Patients Treated with Radiotherapy or Radiochemotherapy
por: Thureau, Sébastien, et al.
Publicado: (2021)

Geometrical Comparison and Quantitative Evaluation of (18)F-FDG PET/CT- and DW-MRI-Based Target Delineation Before and During Radiotherapy for Esophageal Squamous Carcinoma
por: Li, Huimin, et al.
Publicado: (2021)

Delineation of lung cancer with FDG PET/CT during radiation therapy
por: Ganem, J., et al.
Publicado: (2018)

Evaluation of MRI in the diagnostic accuracy of extrahepatic metastases in neuroendocrine tumors in comparison with the reference standard somatostatin-receptor–PET/CT
por: Ingenerf, Maria, et al.
Publicado: (2023)

Changing Role of PET/CT in Cancer Care With a Focus on Radiotherapy
por: Vijayakumar, Srinivasan, et al.
Publicado: (2022)

Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocol
por: le Guevelou, Jennifer, et al.
Publicado: (2020)

Trimodal Therapy vs. Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Meta-Analysis
por: Ding, Hui, et al.
Publicado: (2020)

Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer
por: Guo, Yadong, et al.
Publicado: (2019)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Radiotherapy in Oligometastatic, Oligorecurrent and Oligoprogressive Prostate Cancer: A Mini-Review
por: Yaney, Alexander, et al.
Publicado: (2022)

Prognostic factors associated with (18)FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment
por: Feng, Wei-Hsiang, et al.
Publicado: (2022)

Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer
por: Mallet, Romain, et al.
Publicado: (2020)

Pelvic salvage (SBRT) radiotherapy based on (68)Ga-PSMA PET/CT: About a case
por: Slaoui, A., et al.
Publicado: (2019)

FDG-PET/CT in the Radiotherapy Treatment Planning of Locally Advanced Anal Cancer: A Monoinstitutional Experience
por: Di Carlo, Clelia, et al.
Publicado: (2021)

A Pilot Study of (18)F-DCFPyL PET/CT or PET/MRI and Ultrasound Fusion Targeted Prostate Biopsy for Intra-Prostatic PET-Positive Lesions
por: Liu, Yachao, et al.
Publicado: (2021)

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma
por: Goense, Lucas, et al.
Publicado: (2018)

[18F]FDG PET/CT versus [18F]FDG PET/MRI for the diagnosis of colorectal liver metastasis: A systematic review and meta-analysis
por: Miao, Zhi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aciudght2vm8kkvjrqljca9g1q